![Mainz Biomed Announce IRB Approval and Initiation of US Pivotal FDA Clinical Study | Technology Networks Mainz Biomed Announce IRB Approval and Initiation of US Pivotal FDA Clinical Study | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/368207/mainz-biomed-announce-irb-approval-and-initiation-of-us-pivotal-fda-clinical-study-368207-960x540.jpg?cb=12060639)
Mainz Biomed Announce IRB Approval and Initiation of US Pivotal FDA Clinical Study | Technology Networks
![FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC](https://static.wixstatic.com/media/74925d_3af4052f6fd44a77ba1cf25883b87cba~mv2.jpg/v1/fill/w_714,h_709,al_c,lg_1,q_85/74925d_3af4052f6fd44a77ba1cf25883b87cba~mv2.jpg)
FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC
![Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review - ScienceDirect Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720375331-gr2.jpg)
Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art Review - ScienceDirect
Sample construction of novel therapeutic agents approved by the U.S.... | Download Scientific Diagram
![The Winding Journey From EFS/FIH to Pivotal Study: How to Work Closely With the FDA Through the Ups and Downs | tctmd.com The Winding Journey From EFS/FIH to Pivotal Study: How to Work Closely With the FDA Through the Ups and Downs | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2019-09/2E34327B-D30E-496A-8327-3623BBFA65CE.png)
The Winding Journey From EFS/FIH to Pivotal Study: How to Work Closely With the FDA Through the Ups and Downs | tctmd.com
![Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA | Trials | Full Text Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA | Trials | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13063-021-05790-9/MediaObjects/13063_2021_5790_Fig2_HTML.png)
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA | Trials | Full Text
![FDA Guidance on Design Considerations for Pivotal Clinical Investigations: Non-Comparative Clinical Outcome Studies | RegDesk FDA Guidance on Design Considerations for Pivotal Clinical Investigations: Non-Comparative Clinical Outcome Studies | RegDesk](https://www.regdesk.co/wp-content/uploads/2022/11/istockphoto-1159312593-612x612-1.jpg)
FDA Guidance on Design Considerations for Pivotal Clinical Investigations: Non-Comparative Clinical Outcome Studies | RegDesk
![Major pivotal study leads to FDA approval of the Vivistim Paired VNS System for treatment of upper limb impairments after chronic ischemic stroke | VJNeurology Major pivotal study leads to FDA approval of the Vivistim Paired VNS System for treatment of upper limb impairments after chronic ischemic stroke | VJNeurology](https://www.vjneurology.com/wp-content/uploads/2021/09/VNS.png)
Major pivotal study leads to FDA approval of the Vivistim Paired VNS System for treatment of upper limb impairments after chronic ischemic stroke | VJNeurology
![PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study. - Seroba Life Sciences PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study. - Seroba Life Sciences](https://seroba-lifesciences.com/wp-content/uploads/2019/10/pq-bypass-news-300x300.png)
PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study. - Seroba Life Sciences
![FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC) | DAIC FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC) | DAIC](https://www.dicardiology.com/sites/default/files/inline-images/Figure1.png)
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC) | DAIC
![Early feasibility studies in the United States: Focus on electrophysiology - Weiss - 2023 - Journal of Cardiovascular Electrophysiology - Wiley Online Library Early feasibility studies in the United States: Focus on electrophysiology - Weiss - 2023 - Journal of Cardiovascular Electrophysiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/49123353-3e46-4f29-8104-5ef6949f2dc2/jce15869-fig-0001-m.png)
Early feasibility studies in the United States: Focus on electrophysiology - Weiss - 2023 - Journal of Cardiovascular Electrophysiology - Wiley Online Library
![Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study - Lumira Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study - Lumira](https://www.lumiraventures.com/wp-content/uploads/2022/01/Cordella_Pulmonary_Artery_Pressure_Sensor.jpg)
Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study - Lumira
Metavention's Renal Denervation Pivotal IDE Study now Approved by FDA for the Treatment of Hypertension
![Design of the pivotal Study 311 [19] and Study 312 [13, 20] phase 3... | Download Scientific Diagram Design of the pivotal Study 311 [19] and Study 312 [13, 20] phase 3... | Download Scientific Diagram](https://www.researchgate.net/publication/350164644/figure/fig1/AS:1021236666703872@1620493203303/Design-of-the-pivotal-Study-311-19-and-Study-312-13-20-phase-3-clinical-trials.png)